慢性饮酒对老年人认知功能的影响
Simona-Dana Mitincu-Caramfil1, Alina Plesea-Condratovici2, Alexia Anastasia Stefania Balta2,3
1Department of Pharmaceutical Sciences, Dunărea de Jos University, 800008 Galati, Romania.
Journal of clinical medicine
|July 12, 2025
概括
慢性饮酒的老年人认知障碍很常见,特别是在罗马尼亚农村地区. 肝功能障碍有助于认知能力下降,但在住院治疗后可能有所改善.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 慢性饮酒会显著影响老年人的认知功能.
- 罗马尼亚的城乡差异加剧了与酒精有关的认知缺陷的问题.
- 可逆性肝功能障碍在认知表现中的作用需要进一步研究.
研究的目的:
- 在慢性饮酒的老年患者中使用迷你精神状态检查 (MMSE) 评估认知功能.
- 为了确定农村和城市人口之间的认知功能的差异.
- 分析肝脏标志物和MMSE得分之间的关系.
主要方法:
- 一项对152名因酒精戒断而住院的55岁以上患者进行的回顾性观察性研究.
- 收集人口统计数据,MMSE分数 (入院和出院),以及肝脏参数 (AST,ALT,GGT,总 bilirubin,氨).
- 统计分析包括描述性统计,千二测试,配对t测试/ANOVA和皮尔森相关性.
主要成果:
- 94%的患者在入院时MMSE得分低于24分.
- 住院后的MMSE平均得分从23.4提高到25.0 (p < 0.001).
- 与城市患者 (24.8) 相比,农村患者的入院MMSE得分 (22.6) 较低 (p = 0.02),在出院时的差距仍然存在.
- 高的玛-氨基转移酶 (GGT) 水平与MMSE得分呈反向相关性 (r = -0.41; p < 0.001).
结论:
- 与酒精有关的认知障碍在接受戒断治疗的住院老年人中非常普遍.
- 住院治疗可以导致部分认知能力的改善,但农村的差异仍然存在.
- 同时对认知功能 (MMSE) 和肝功能障碍进行查至关重要,重点是农村干预.
更多相关视频
相关概念视频
Cognitive Development During Adulthood
289
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
289
CNS Depressants: Alcohol and Nicotine
364
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
364
Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673
Aging
188
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
188
Role of Neurotransmitters in Memory
1.0K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
1.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
212
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
212


